Concepedia

Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas

Marlo Blazer, Christina Wu, Richard M. Goldberg, Gary Phillips, Carl Schmidt, Peter Muscarella, Evan Wuthrick, Terrence M. Williams, Joshua Reardon, E. Christopher Ellison,

Annals of Surgical Oncology · 2014 · 250 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

, , +16

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

, , +13

Hepatogastroenterology

Liping Chen, Ning Li, Hui Ye · Hepatogastroenterology · 2012 · 3.2K citations

, , +17

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

, , +13

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

Mark P. Callery, Kenneth J. Chang, Elliot K. Fishman et al. · Annals of Surgical Oncology · 2009 · 898 citations

, , +16